Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 50% Gains Investing -- Ignore unavailable to you. Want to Upgrade?

To: Bocor who wrote (27214)	9/27/2001 8:04:58 AM
From: Dale Baker	Read Replies (1) \| Respond to of 118717

Conference call on VGIN approval today too: Visible Genetics Inc. Invites You to Join Its Conference Call on the Web Discussing the FDA Clearance for Its TRUGENE HIV-1 Genotyping Test TORONTO, Sept. 27 /PRNewswire/ -- Visible Genetics Inc. (Nasdaq: VGIN - news) invites you to listen to its conference call that will be broadcast live over the Internet on September 27, 2001 at 11:00 AM Eastern Time with Richard T. Daly, President and CEO of Visible Genetics Inc. What: Visible Genetics Receives FDA Clearance of TRUGENE HIV-1 Genotyping Test When: September 27th at 11:00 AM Eastern Time Where: videonewswire.com How: Live over the Internet -- Simply log on to the web at the address above Contact: Bruno Maruzzo 416-813-3271 bruno@visgen.com Visible Genetics Inc. is a leader in the emerging field of pharmacogenomics, which uses genetic information in the identification and analysis of genes to improve patient care and reduce healthcare costs. VGI manufactures and markets high performance automated DNA sequencing systems and complete kits for the analysis of genes linked to disease. The Company's OpenGene(TM) system employs patented CLIP technology -- a single-step, bi-directional sequencing method that significantly reduces the time and cost involved in identifying clinically relevant genetic information.

To: Bocor who wrote (27214)	9/27/2001 9:11:26 AM
From: Henrik	Respond to of 118717

VGIN < ZAXS <PGLAF - Great news about the FDA approval for VGIN. Now watch for flow-on effect to other related stock. ZAXS.OB is the supplier of gel used in the VGIN kit. biz.yahoo.com Progen - NASDAQ:PGLAF ASX:PGL in turn now hold ~7% interest in ZAXS. biz.yahoo.com About Progen - Progen is an Australian biotech company with Phase I/II trial of anti-cancer drug PI-88. for more details see progen.com.au About Zaxis zaxis-inc.com About Visible Genetics Inc. visgen.com Discloser - position in PGLAF, ZAXS & VGIN